Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vera Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 1 insider, $4.67M in total
- Insiders trading
- 1
- Net value
- −$4.67M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vera Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO | 235,244 | Sep 17, 2026 | 8 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 80,754 | Sep 14, 2026 | 5 |
| Boman Nancy Lee | Chief Regulatory Officer | 44,987 | Aug 5, 2026 | 1 |
| Seidenberg Beth C | Director | 131,553 | May 26, 2026 | 1 |
| Morrissey Michael | Director | – | May 26, 2026 | 1 |
| Enright Patrick G | Director | 5,882 | May 26, 2026 | 2 |
| Meyers James R | Director | – | May 26, 2026 | 2 |
| Morrison Scott W | Director | – | May 26, 2026 | 1 |
| Cheng Andrew | Director | – | May 26, 2026 | 1 |
| Oliger Christy J. | Director | – | May 26, 2026 | 1 |
| Hall Kimball | Director | – | May 26, 2026 | 1 |
| Wright-Mitchell Jane | Chief Legal Officer | 42,403 | Mar 25, 2026 | 1 |
| Hite Christopher | Director | – | Mar 9, 2026 | 1 |
| Johnson David Lee | Chief Operating Officer | 45,727 | Feb 25, 2026 | 2 |
| Turner William D. | Chief Regulatory Officer | 45,313 | Feb 25, 2026 | 5 |
| Grant Sean | CHIEF FINANCIAL OFFICER | 114,181 | Feb 25, 2026 | 2 |
| Brenner Robert | Chief Medical Officer | 50,947 | Feb 25, 2026 | 2 |
| Skelton Laurence Matthew | Chief Commercial Officer | 64,218 | Feb 25, 2026 | 2 |
| Carter Jason S | Chief Legal Officer | 49,136 | Nov 25, 2025 | 1 |
| Katabi Maha | Director | 2,793,987Indirect | May 16, 2025 | 0 |
| Commodore Capital LP | 10% Owner | 4,400,000Indirect | Jan 12, 2024 | 0 |
| Curley Joanne | Chief Development Officer | 26,962 | Aug 23, 2023 | 0 |
| Lin Celia | Chief Medical Officer | 11,010 | Aug 23, 2023 | 0 |
| Tammenoms Bakker Juliet | 10% Owner | 1,714,285Indirect | Feb 8, 2023 | 0 |
| Longitude Venture Partners IV, L.P. | 10% Owner | 1,714,285Indirect | Feb 8, 2023 | 0 |
| Longitude Capital Partners IV, LLC | 10% Owner | 1,714,285Indirect | Feb 8, 2023 | 0 |
| Longitude Prime Partners, LLC | 10% Owner | 1,714,285Indirect | Feb 8, 2023 | 0 |
| Longitude Prime Fund, L.P. | 10% Owner | 1,714,285Indirect | Feb 8, 2023 | 0 |
| Healy James | 10% Owner | 3,467,156 | Feb 8, 2023 | 0 |
| Sofinnova Management X, L.P. | 10% Owner | 3,467,156 | Feb 8, 2023 | 0 |
| Sofinnova Venture Partners X, L.P. | 10% Owner | 3,467,156 | Feb 8, 2023 | 0 |
| Sofinnova Management X-A, L.L.C. | 10% Owner | 3,467,156 | Feb 8, 2023 | 0 |
| TC Group, LLC | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Investment Management LLC | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Abingworth LLP | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Group Inc. | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Holdings I GP Inc. | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Holdings I GP Sub L.L.C. | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Holdings I L.P. | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| CG Subsidiary Holdings L.L.C. | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Abingworth Bioventures 8 LP | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
| Carlyle Genesis UK LLC | 10% Owner | 2,960,231Indirect | Aug 19, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 (view filing)6:17 PM ET | Feb 10 | 4 days | Katabi Maha and 3 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +266.7K | $15.00 | +$4.00M | +9.1%3.18M after | |
| Apr 5, 2022 (view filing) | Feb 10 | 54 daysLate | Enright Patrick GDirector, 10% Owner | PPurchaseClass A Common Stock | +333.3K | $15.00 | +$5.00M | +10.8%3.43M after | |
| Apr 5, 2022 (view filing)7:24 AM ET | Feb 10 | 54 daysLate | Tammenoms Bakker Juliet and 2 others10% Owner | PPurchaseClass A Common Stock | +333.3K | $15.00 | +$5.00M | +10.8%3.43M after | Duplicate filing |
| Jun 2, 2022 (view filing) | May 31 | 2 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −400 | $15.22 | −$6.09K | −1.6%25.2K after | |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +5.00K | $13.60 | +$68.0K | New position992 after | 4 lots |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −5.89K | $15.05 | −$88.6K | −19.7%24.0K after | 3 lots |
| Jun 23, 2022 (view filing) | Jun 22 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −1.54K | $15.01 | −$23.2K | −6.1%23.7K after | 2 lots |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −9.67K | $15.05 | −$145.5K | −31.5%21.0K after | 3 lots |
| Jul 15, 2022 (view filing) | Jul 14 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −9.10K | $15.14 | −$137.9K | −33.3%18.3K after | 2 lots |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −11.4K | $16.02 | −$183.3K | −38.5%18.3K after | 4 lots |
| Aug 4, 2022 (view filing) | Aug 3 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −988 | $16.81 | −$16.6K | −5.4%17.3K after | |
| Aug 15, 2022 (view filing) | Aug 12 | 3 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −20.5K | $20.16 | −$413.8K | −13.0%137.4K after | |
| Aug 19, 2022 (view filing)4:39 PM ET | Aug 17 | 2 days | TC Group, LLC and 9 others10% Owner | SSaleClass A Common Stock | −9.93K | $20.25 | −$201.0K | −0.3%2.96M after | 3 lots |
| Aug 23, 2022 (view filing) | Aug 19-22 | 4 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −8.54K | $19.13 | −$163.4K | −22.3%29.8K after | 8 lots |
| Sep 6, 2022 (view filing) | Sep 1-2 | 5 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −34.2K | $21.09 | −$721.3K | −15.9%181.2K after | From original3 lots |
| Sep 8, 2022 (view filing) | Sep 7 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −988 | $18.63 | −$18.4K | −3.3%28.8K after | |
| Sep 9, 2022 (view filing) | Sep 7-8 | 2 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −21.9K | $20.37 | −$445.9K | −10.8%181.2K after | 2 lots |
| Sep 13, 2022 (view filing) | Sep 9-12 | 4 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −29.0K | $20.43 | −$592.8K | −13.8%181.2K after | 3 lots |
| Sep 14, 2022 (view filing) | Sep 13 | 1 day | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −22.4K | $21.16 | −$473.2K | −11.0%181.2K after | 2 lots |
| Sep 22, 2022 (view filing) | Sep 20-21 | 2 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −16.8K | $20.72 | −$348.9K | −36.9%28.8K after | 8 lots |
| Oct 5, 2022 (view filing) | Oct 3-4 | 2 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −32.0K | $20.90 | −$668.8K | −15.0%181.2K after | 5 lots |
| Oct 6, 2022 (view filing) | Oct 5 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −988 | $21.64 | −$21.4K | −3.4%27.8K after | |
| Oct 20, 2022 (view filing) | Oct 18 | 2 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −8.59K | $19.41 | −$166.8K | −23.6%27.8K after | 4 lots |
| Nov 10, 2022 (view filing) | Nov 9 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −494 | $16.54 | −$8.17K | −1.8%27.3K after | |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −3.29K | $15.85 | −$52.1K | −10.7%27.3K after | 2 lots |
| Dec 8, 2022 (view filing) | Dec 7 | 1 day | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −494 | $16.47 | −$8.14K | −1.8%26.8K after | |
| Dec 14, 2022 (view filing) | Dec 12-13 | 2 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −19.7K | $18.26 | −$360.0K | −42.4%26.8K after | 3 lots |
| Dec 19, 2022 (view filing) | Dec 16 | 3 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −2.21K | $19.49 | −$43.1K | −7.6%26.8K after | 2 lots |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Enright Patrick GDirector, 10% Owner | PPurchaseClass A Common Stock | +1.71M | $7.00 | +$12.0M | New position1.71M after | |
| Feb 8, 2023 (view filing)6:29 PM ET | Feb 6 | 2 days | Katabi Maha and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +285.7K | $7.00 | +$2.00M | +9.0%3.47M after | |
| Feb 8, 2023 (view filing)7:40 PM ET | Feb 6 | 2 days | Tammenoms Bakker Juliet and 4 others10% Owner | PPurchaseClass A Common Stock | +1.71M | $7.00 | +$12.0M | New position1.71M after | Duplicate filing |
| Feb 9, 2023 (view filing) | Feb 3-8 | 6 daysLate | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +311.1K | $7.10 | +$2.21M | +23.2%1.65M after | 4 lots |
| Feb 13, 2023 (view filing) | Feb 9 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +400 | $7.25 | +$2.90K | 0.0%1.65M after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +10.1K | $7.20 | +$72.5K | +0.6%1.66M after | |
| Feb 17, 2023 (view filing) | Feb 6 | 11 days | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +14.3K | $7.00 | +$100.0K | +40.1%49.9K after | Amended |
| Feb 17, 2023 (view filing) | Feb 6 | 11 days | Young Joseph RSVP, Finance, Chief Acct Offcr | PPurchaseClass A Common Stock | +5.71K | $7.00 | +$40.0K | +33.7%22.7K after | Amended |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +200 | $7.24 | +$1.45K | 0.0%1.66M after | |
| Mar 3, 2023 (view filing) | Mar 1-2 | 2 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +23.5K | $7.24 | +$170.0K | +1.4%1.69M after | 2 lots |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +1.00K | $7.25 | +$7.25K | +0.1%1.69M after | |
| Mar 14, 2023 (view filing) | Mar 10 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +48.0K | $7.16 | +$343.7K | +2.8%1.74M after | |
| Mar 17, 2023 (view filing) | Mar 15-16 | 2 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +92.9K | $7.10 | +$659.9K | +5.3%1.83M after | 2 lots |
| Mar 21, 2023 (view filing) | Mar 17-20 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +89.3K | $7.14 | +$637.2K | +4.9%1.92M after | 2 lots |
| Mar 28, 2023 (view filing) | Mar 24-27 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +3.47K | $7.24 | +$25.1K | +0.2%1.92M after | 2 lots |
| Mar 30, 2023 (view filing) | Mar 28 | 2 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +23.9K | $7.24 | +$173.1K | +1.2%1.95M after | |
| Apr 3, 2023 (view filing) | Mar 30 | 4 days | Seidenberg Beth CDirector | PPurchaseClass A Common Stock | +2.30K | $7.24 | +$16.7K | +0.1%1.95M after | |
| Jun 22, 2023 (view filing) | Jun 20 | 2 days | Commodore Capital LP10% Owner | PPurchaseClass A Common Stock | +448.2K | $15.17 | +$6.80M | +9.0%5.45M after | |
| Jun 23, 2023 (view filing) | Jun 23 | Same day | Grant SeanChief Financial Officer | PPurchaseClass A Common Stock | +5.00K | $16.60 | +$83.0K | +504.0%5.99K after | |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Fordyce MarshallPresident and CEO | SSaleClass A Common Stock | −5.21K | $16.66 | −$86.8K | −2.1%243.4K after | 10b5-1 |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Curley JoanneChief Development Officer | SSaleClass A Common Stock | −1.49K | $16.66 | −$24.8K | −5.2%27.0K after | 10b5-1 |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Lin CeliaChief Medical Officer | SSaleClass A Common Stock | −1.49K | $16.65 | −$24.8K | −11.9%11.0K after | 10b5-1 |